MicroRNA 3682 (miR-3682 (or hsa-miR-3682))

MicroRNA 3682 (miR-3682, also known as hsa-miR-3682 or MIR3682) is a short, non-coding RNA belonging to the microRNA family. miR-3682 is transcribed as part of a longer primary transcript, processed by Drosha and Dicer enzymes to generate the mature microRNA molecule, which is incorporated into the RNA-induced silencing complex (RISC). Its primary function is the post-transcriptional regulation of gene expression through sequence-specific interactions with target mRNAs, leading to mRNA degradation or translational inhibition. Recent research highlights miR-3682-3p as a candidate biomarker for diagnosis and prognosis in hepatocellular carcinoma, with expression patterns associated with tumor presence and clinical outcomes[2][3]. Like other microRNAs, it potentially impacts a broad array of biological processes and its dysregulation may contribute to disease pathogenesis, most notably in cancer. No direct drug interactions or targeted therapeutics for miR-3682 are documented as of now.

Other names

hsa-mir-3682mir-3682MIR3682miR-3682-3p

Not directly targeted by drugs; microRNAs generally regulate gene expression by base pairing with mRNA, leading to translational inhibition or degradation[2][3] - Therapeutic manipulation (if developed) would likely involve modulation of miR-3682 mimics or inhibitors (antagomirs), but such agents are not documented specifically for miR-3682 as of the current literature